Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers
Status:
Completed
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
A randomized, single-center, double-blind, ascending multiple-dose, placebo-controlled study
to evaluate the tolerability and pharmacokinetics of CSPCHA115 capsules in Chinese healthy
volunteers.